Key Events This Week
3 Aug: Q1 FY27 results reveal profit surge despite revenue concerns
4 Aug: Mixed quarterly results reported alongside technical momentum shift
5 Aug: Stock rebounds modestly amid positive short-term technical signals
7 Aug: Week closes at Rs.593.80, down 5.30% for the week

Blue Jet Healthcare Ltd is Rated Hold by MarketsMOJO
2026-08-07 10:12:01Blue Jet Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAre Blue Jet Healthcare Ltd latest results good or bad?
2026-08-04 19:22:00Blue Jet Healthcare Ltd's latest financial results for Q1 FY27 present a mixed picture, highlighting both sequential recovery and ongoing challenges. The company reported a net profit of ₹78.26 crores, reflecting a quarter-on-quarter growth of 21.64%, while revenue reached ₹293.11 crores, marking a 24.90% increase from the previous quarter. Additionally, the operating margin improved to 33.46%, up 309 basis points from the prior quarter. However, the year-on-year comparisons reveal a different narrative, with revenue declining by 17.38% from ₹354.76 crores in June 2025, and net profit down 14.14% from the same period. This marks the third consecutive quarter of year-on-year revenue contraction, suggesting potential structural challenges within the company that may need to be addressed. Despite the sequential gains, the overall financial trend remains concerning, as six-month metrics indicate a decline in ...
Read full news article
Blue Jet Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-04 08:10:53Blue Jet Healthcare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent 6.00% decline in its share price to ₹589.40, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes. This article analyses the evolving price momentum, key technical indicators such as MACD, RSI, moving averages, and their implications for investors.
Read full news article
Blue Jet Healthcare Ltd Reports Mixed Quarterly Results Amid Financial Trend Improvement
2026-08-04 08:00:24Blue Jet Healthcare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in its financial trend for the quarter ended June 2026. While the company’s recent quarterly results show encouraging growth in key metrics such as net sales and profitability, challenges remain in the half-year performance and operational efficiency, prompting a cautious Hold rating upgrade from Sell.
Read full news article
Blue Jet Healthcare Q1 FY27: Profit Surge Masks Revenue Decline Concerns
2026-08-03 17:47:06Blue Jet Healthcare Ltd. reported a sharp sequential profit recovery in Q1 FY27, with net profit jumping 21.64% quarter-on-quarter to ₹78.26 crores, yet the pharmaceutical manufacturer continues to grapple with a concerning year-on-year revenue contraction of 17.38%, raising questions about the sustainability of its recent profitability rebound. The stock, with a market capitalisation of ₹11,920 crores, closed 6.00% lower at ₹589.40 following the results announcement, suggesting investor scepticism about the company's ability to reverse its top-line decline.
Read full news articleWhen is the next results date for Blue Jet Healthcare Ltd?
2026-07-29 23:17:29The next results date for Blue Jet Healthcare Ltd is scheduled for August 3, 2026....
Read full news article
Blue Jet Healthcare Ltd is Rated Hold
2026-07-27 10:10:55Blue Jet Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 Jul 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article





